Literature DB >> 12215537

Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein.

Kristine McKinney1, Carol Prives.   

Abstract

The nonhistone chromosomal protein high-mobility group 1 protein (HMG-1/HMGB1) can serve as an activator of p53 sequence-specific DNA binding (L. Jayaraman, N. C. Moorthy, K. G. Murthy, J. L. Manley, M. Bustin, and C. Prives, Genes Dev. 12:462-472, 1998). HMGB1 is capable of interacting with DNA in a non-sequence-specific manner and causes a significant bend in the DNA helix. Since p53 requires a significant bend in the target site, we examined whether DNA bending by HMGB1 may be involved in its enhancement of p53 sequence-specific binding. Accordingly, a 66-bp oligonucleonucleotide containing a p53 binding site was locked in a bent conformation by ligating its ends to form a microcircle. Indeed, p53 had a dramatically greater affinity for the microcircle than for the linear 66-bp DNA. Moreover, HMGB1 augmented binding to the linear DNA but not to the microcircle, suggesting that HMGB1 works by providing prebent DNA to p53. p53 contains a central core sequence-specific DNA binding region and a C-terminal region that recognizes various forms of DNA non-sequence specifically. The p53 C terminus has also been shown to serve as an autoinhibitor of core-DNA interactions. Remarkably, although the p53 C terminus inhibited p53 binding to the linear DNA, it was required for the increased affinity of p53 for the microcircle. Thus, depending on the DNA structure, the p53 C terminus can serve as a negative or a positive regulator of p53 binding to the same sequence and length of DNA. We propose that both DNA binding domains of p53 cooperate to recognize sequence and structure in genomic DNA and that HMGB1 can help to provide the optimal DNA structure for p53.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215537      PMCID: PMC134028          DOI: 10.1128/MCB.22.19.6797-6808.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

Review 1.  Covalent and noncovalent modifiers of the p53 protein.

Authors:  L Jayaraman; C Prives
Journal:  Cell Mol Life Sci       Date:  1999-01       Impact factor: 9.261

2.  p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting.

Authors:  A K Nagaich; V B Zhurkin; S R Durell; R L Jernigan; E Appella; R E Harrington
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

3.  Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.

Authors:  I Takenaka; F Morin; B R Seizinger; N Kley
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

4.  Specific mismatch recognition in heteroduplex intermediates by p53 suggests a role in fidelity control of homologous recombination.

Authors:  C Dudenhöffer; G Rohaly; K Will; W Deppert; L Wiesmüller
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

6.  The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.

Authors:  J H Bayle; B Elenbaas; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

7.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

8.  p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain.

Authors:  G Bakalkin; G Selivanova; T Yakovleva; E Kiseleva; E Kashuba; K P Magnusson; L Szekely; G Klein; L Terenius; K G Wiman
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

9.  High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.

Authors:  S Zwilling; H König; T Wirth
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

Authors:  K Okamoto; D Beach
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  50 in total

1.  General transcriptional coactivator PC4 activates p53 function.

Authors:  Sourav Banerjee; B R Prashanth Kumar; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

2.  Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.

Authors:  Taeyoung Koo; Il-Kyu Choi; Minjung Kim; Jung-Sun Lee; Eonju Oh; Jungho Kim; Chae-Ok Yun
Journal:  Hum Gene Ther       Date:  2012-02-21       Impact factor: 5.695

3.  Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.

Authors:  K Völp; M-L Brezniceanu; S Bösser; T Brabletz; T Kirchner; D Göttel; S Joos; M Zörnig
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

4.  The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.

Authors:  Andrei L Okorokov; Michael B Sherman; Celia Plisson; Vera Grinkevich; Kristmundur Sigmundsson; Galina Selivanova; Jo Milner; Elena V Orlova
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

5.  Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.

Authors:  Robert D Kendig; Fumitake Kai; Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Invest       Date:  2017-04-13       Impact factor: 2.176

6.  p53 binding to nucleosomal DNA depends on the rotational positioning of DNA response element.

Authors:  Geetaram Sahu; Difei Wang; Claudia B Chen; Victor B Zhurkin; Rodney E Harrington; Ettore Appella; Gordon L Hager; Akhilesh K Nagaich
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  Activation of p53 function by human transcriptional coactivator PC4: role of protein-protein interaction, DNA bending, and posttranslational modifications.

Authors:  Kiran Batta; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

Review 8.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

9.  High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

Authors:  Natalia Krynetskaia; Hongbo Xie; Slobodan Vucetic; Zoran Obradovic; Evgeny Krynetskiy
Journal:  Mol Pharmacol       Date:  2007-10-19       Impact factor: 4.436

10.  Functions of MutLalpha, replication protein A (RPA), and HMGB1 in 5'-directed mismatch repair.

Authors:  Jochen Genschel; Paul Modrich
Journal:  J Biol Chem       Date:  2009-06-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.